Institutional Ownership
Ascendis Pharma A/S
CUSIP 04351PAD3NOTE 2.250% 4/0ASNDQ1 2026
13D / 13G Filings
0
Schedule 13D/13G on record
Beneficial Filers
0
Distinct reporting persons
Largest Stake
—
Max % of class reported
Institutional Holders
8
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
Schedule 13D (activist) & 13G (passive) 5%+ ownership filings
No 13D/13G filings on record yet
Schedule 13D/13G beneficial-ownership filings from 2020–present are ingested from SEC EDGAR. Coverage expands as the backfill and daily crawler run.
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Boussard & Gavaudan Investment Management LLP | 12.9K | $18.83M |
| 2 | Ssi Investment Management LLC | 10.83M | $15.89M |
| 3 | Polar Capital Holdings PLC | 3.50M | $5.11M |
| 4 | Balyasny Asset Management L.P. | 3.00M | $4.41M |
| 5 | State Of Wisconsin Investment Board | 3.00M | $4.40M |
| 6 | Loomis Sayles & Co L P | 16.0K | $3.67M |
| 7 | Bnp Paribas Asset Management Holding S.A. | 2.00M | $2.97M |
| 8 | Oddo Bhf Asset Management Sas | 161 | $237.0K |